The Chair of the Health and Social Care Committee of the UK House of Commons wrote on 7 November 2018 to Vertex, the National Health Service (“NHS England”) and the National Institute for Health and Care Excellence (“NICE”) to request pricing information regarding the cystic fibrosis medicine Orkambi® (see attached letters). The move follows two-and-a-half years of unsuccessful pricing negotiations between these parties.

The College of Prosecutors of the Belgian Competition Authority (“BCA”) announced on 8 November 2018 that it has submitted a draft infringement decision to the Competition College with the request to review the Prosecutors’ findings and take a final decision against the professional organisation of pharmacists known as “Orde der Apothekers”/”Ordre des pharmaciens” (the “PO”).